arrow
返回
M

Mats O. Karlsson

uppsala university

66H指数
621论文数
2.0W被引数
收录论文 211
发表时间
Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study跨国成本-效用分析:基于U-PGx PREPARE研究中入组患者的药理学基因指导治疗
err2025-12-16
err0
errOAAI
errVasileios Fragoulakis; Jesse J. Swen; Margarita-Ioanna Koufaki; Kathrin Blagec; Tanja Blagus; Stefan Böhringer; Anne Cambon-Thomsen; Erika Cecchin; Ka-Chun Cheung; Vera H.M. Deneer; Mathilde Dupui; Siv Jonsson; Candace Joefield-Roka; Katja S. Just; Mats O. Karlsson; Lidija Konta; Rudolf Koopmann; Marjolein Kriek; Thorsten Lehr; Lisanne E.N. Manson
err分享
err收藏
Predictors of Ability to Work in Multiple Sclerosis多发性硬化患者工作能力的影响因素
err2025-11-04
err0
errOAAI
errGustaf J. Wellhagen; Sebastian Ueckert; Elisabet Nielsen; Carl Smith; Xinyi Li; Joachim Burman; Mats O. Karlsson
err分享
err收藏
Early prediction of subsequent peg-asparaginase inactivation in acute lymphoblastic leukaemia patients—A NOPHO ALL2008 study急性淋巴细胞白血病患者后续培门冬酶失活的早期预测——一项NOPHO ALL2008研究
err2025-09-07
err0
errOAAI
errMerete Dam; Maddalena Centanni; Daniel Centanni; Lena E. Friberg; Mats O. Karlsson; Line S. Lynggaard; Inga M. Johannsdottir; Kristi Lepik; Goda E. Vaitkeviciene; Laimonas Griskevicius; Tuuli Pöyhönen; Marja Pyörälä; Ólafur G. Jónsson; Petter Quist-Paulsen; Kjeld Schmiegelow; Tania Christoforaki; Ulrik Overgaard; Stefan N. Hansen; Birgitte K. Albertsen
err分享
err收藏
A Pharmacometrics-Informed Trial Simulation Framework for Optimizing Study Designs for Disease-Modifying Treatments in Rare Neurological Disorders基于药代动力学信息指导的试验模拟框架,用于优化罕见神经系统疾病疾病修饰性治疗的研究设计
err2025-08-05
err0
errOAAI
errYevgen Ryeznik; Ralf-Dieter Hilgers; Nicole Heussen; Emmanuelle Comets; France Mentré; Niels Hendrickx; Mats O. Karlsson; Andrew C. Hooker; Alzahra Hamdan; Xiaomei Chen; Rebecca Schüle; Matthis Synofzik; Oleksandr Sverdlov
err分享
err收藏
Integrated Modeling of Digital-Motor and Clinician-Reported Outcomes Using Item Response Theory: Towards Powerful Trials for Rare Neurological Diseases基于项目反应理论的数字-运动与临床报告结局的整合建模:面向罕见神经疾病的强力试验
err2025-07-21
err0
errOAAI
errAlzahra Hamdan; Andreas Traschütz; Lukas Beichert; Xiaomei Chen; Cynthia Gagnon; Bart P. van de Warrenburg; Filippo M. Santorelli; Nazlı Başak; Giulia Coarelli; Rita Horvath; Stephan Klebe; PROSPAX consortium; EVIDENCE-RND consortium; Rebecca Schüle; Andrew C. Hooker; Matthis Synofzik; Mats O. Karlsson
err分享
err收藏
Competing Risks Analysis of the Finnish Diabetes Prevention Study芬兰糖尿病预防研究的竞争风险分析
err2025-06-30
err0
errOAAI
errMoustafa M. A. Ibrahim; Matti Uusitupa; Jaakko Tuomilehto; Jaana Lindström; Maria C. Kjellsson; Mats O. Karlsson
err分享
err收藏
Pharmacogenetic Implementation Studies—Lessons Learned From the PREPARE Study药物基因组学实施研究——来自PREPARE研究的经验教训
err2025-06-24
err0
errOAAI
errHenk-Jan Guchelaar; Cathelijne H. van der Wouden; Lisanne E. N. Manson; Heshu Abdullah-Koolmees; Kathrin Blagec; Tanja Blagus; Stefan Böhringer; Erika Cecchin; Ka-Chun Cheung; Vera H. M. Deneer; Siv Jonsson; Candace Joefield-Roka; Katja S. Just; Mats O. Karlsson; Lidija Konta; Rudolf Koopmann; Marjolein Kriek; Thorsten Lehr; Christina Mitropoulou; Victoria Rollinson; Rossana Roncato; Matthias Samwald; Elke Schaeffeler; Maria Skokou; Matthias Schwab; Daniela Steinberger; Julia C. Stingl; Roman Tremmel; Richard M. Turner; Mandy H. van Rhenen; Cristina L. Dávila-Fajardo; Vita Dolžan; George P. Patrinos; Munir Pirmohamed; Gere Sunder-Plassmann; Giuseppe Toffoli; Jesse J. Swen; Ubiquitous Pharmacogenomics Consortium
err分享
err收藏
Population pharmacokinetics and dosing of dispersible moxifloxacin formulation in children with rifampicin-resistant tuberculosis
err2025-02-17
err0
errOAAI
errPalmer, Megan; Zou, Yuanxi; Hesseling, Anneke C.; van Der Laan, Louvina; Courtney, Ingrid; Kinikar, Aarti A.; Sonkawade, Naresh; Paradkar, Mandar; Kulkarni, Vandana; Casalme, Dessa Jean O.; Frias, Melchor V. G.; Draper, Heather; Wiesner, Lubbe; Karlsson, Mats O.; Denti, Paolo; Svensson, Elin M.; Garcia-Prats, Anthony J.
err分享
err收藏